Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 08 Jul 2021
Last Applicant/ Owned by
31 West 31st Street
New York
NY
10001
Serial Number
90281316 filed on 27th Oct 2020
Registration Number
N/A
Filing Basis
1. use application currently
Disclaimer
NO DATA
MATRIPTIMAB
Matriptimab is a novel antibody-drug conjugate that targets activated matriptase, a tumor antigen expressed almost exclusively on cancer cells
Classification Information
Class [005]
Pharmaceutical Products
Matriptimab is a novel antibody-drug conjugate that targets activated matriptase, a tumor antigen expressed almost exclusively on cancer cells
First Use Date in General
22nd Mar 2018
First Use Date in Commerce
22nd Mar 2018
Mark Details
Serial Number
No 90281316
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 112.04
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Jul 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 08th Jul 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 23rd Dec 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 23rd Dec 2020 | NON-FINAL ACTION E-MAILED |
| 23rd Dec 2020 | NON-FINAL ACTION WRITTEN |
| 23rd Dec 2020 | ASSIGNED TO EXAMINER |
| 17th Dec 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 30th Oct 2020 | NEW APPLICATION ENTERED IN TRAM |